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A B S T R A C T
Friedreich ataxia (FA) is a cardioneurodegenerative disease caused by deficient frataxin expression. This mitochondrial protein has been related to iron homeostasis,
energy metabolism, and oxidative stress. Previously, we set up a cardiac cellular model of FA based on neonatal rat cardiac myocytes (NRVM) and lentivirus-
mediated frataxin RNA interference. These frataxin-deficient NRVMs presented lipid droplet accumulation, mitochondrial swelling and signs of oxidative stress.
Therefore, we decided to explore the presence of protein thiol modifications in this model. With this purpose, reduced glutathione (GSH) levels were measured and
the presence of glutathionylated proteins was analyzed. We observed decreased GSH content and increased presence of glutahionylated actin in frataxin-deficient
NRVMs. Moreover, the presence of oxidized cysteine residues was investigated using the thiol-reactive fluorescent probe iodoacetamide-Bodipy and 2D-gel elec-
trophoresis. With this approach, we identified two proteins with altered redox status in frataxin-deficient NRVMs: electron transfer flavoprotein-ubiquinone oxi-
doreductase and dihydrolipoyl dehydrogenase (DLDH). As DLDH is involved in protein-bound lipoic acid redox cycling, we analyzed the redox state of this cofactor
and we observed that lipoic acid from pyruvate dehydrogenase was more oxidized in frataxin-deficient cells. Also, by targeted proteomics, we observed a decreased
content on the PDH A1 subunit from pyruvate dehydrogenase. Finally, we analyzed the consequences of supplementing frataxin-deficient NRVMs with the PDH
cofactors thiamine and lipoic acid, the PDH activator dichloroacetate and the antioxidants N-acetyl cysteine and Tiron. Both dichloroacetate and Tiron were able to
partially prevent lipid droplet accumulation in these cells. Overall, these results indicate that frataxin-deficient NRVMs present an altered thiol-redox state which
could contribute to the cardiac pathology.
1. Introduction
Friedreich ataxia (FA) is a rare disease caused by decreased ex-
pression of frataxin, a nuclear encoded protein with mitochondrial lo-
calization. Frataxin is highly expressed in the heart and the nervous
system, and consequently these tissues are among the most affected in
FA. The first symptoms of the disease are usually neurologic [1], while
the primary cause of death in most FA patients is related to cardio-
myopathy [2].
Many evidences indicate that at the cellular level frataxin deficiency
alters cellular iron homeostasis and causes oxidative stress. Two po-
tential mechanisms have been proposed to explain these phenotypes,
the iron-sulfur hypothesis and the iron toxicity hypothesis (reviewed in
Refs. [3–6]). The first one suggests that frataxin contributes to iron-
sulfur cluster biogenesis, which are cofactors required for the activity of
many proteins and also for iron sensing. Therefore, its deficiency would
activate an iron deficiency signal that would promote iron uptake. In
support of this hypothesis, it has been shown that frataxin localizes to
mitochondria where it may interact and regulate the activity of cysteine
desulfurase [7]. This enzyme is required for providing sulfide for the
biosynthesis of several cofactors, such as iron-sulfur clusters, mo-
lybdenum cofactor and lipoic acid [8]. Although this hypothesis is well
supported by in vitro data, its major caveat is the absence of iron-sulfur
clusters deficiency in many models of frataxin deficiency. The iron
toxicity hypothesis is based on the known ability of frataxin to bind iron
[9]. According to this hypothesis frataxin deficiency would lead to in-
creased free iron which would catalyze ROS generation.
Oxidative stress in frataxin-deficient cells may also be enhanced by
an impaired activation of the Nrf2 signaling pathway [10]. This phe-
nomenon has been observed in several models of the disease and it has
been related to actin remodelling, which in turn could be caused by
glutahionylation of this protein. This modification is caused by the
formation of disulphide bonds between protein thiol groups and glu-
tathione. Glutathione is a cysteine-containing tripeptide present in
millimolar concentrations in the cell and involved in a wide range of
processes which include: i) serving as electron donor to glutathione
peroxidases or peroxiredoxins for scavenging reactive oxygen species
[11]; ii) protecting proteins form irreversible thiol modifications or
regulating its activity by glutahionylation (which can be reversed by
glutaredoxins) [12]; iii) protecting from heavy metals toxicity through
its chelation and export [13]; iv) participating in xenobiotic detox-
ification in collaboration with glutathione S-transfesares [14]. It has
also been postulated that glutathione could act as a ligand of the labile
iron pool and contribute to cellular iron homestasis [15]. Free
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glutahione can be found in its reduced form (GSH) or as an oxidized
disulphide (GSSG) [16]. In this regard, in several models of FA it has
been observed a decreased GSH/GSSG ratio and an increased presence
of glutathionylated actin [17,18]. Both events (actin glutathionylation
and decreased GSH/GSSG ratio) are indicative of an imbalance in the
cellular thiol redox status of frataxin-deficient cells.
Despite cardiomyopathy is the leading cause of death in FA, the
specific effects of frataxin deficiency in the heart are poorly understood
and very few cellular models have been used to analyse the mechanisms
linking frataxin deficiency to impaired cardiac function. In this regard,
we have previously investigated the consequences of frataxin deficiency
in neonatal cardiac rat myocytes (NRVM) and we have observed that in
these cells frataxin deficiency leads to marked mitochondrial disar-
rangements and impaired lipid metabolism [19]. In this model we have
also observed increased protein carbonyl content and increased sensi-
tivity to tert-butyl hydroperoxide, which are clear markers of oxidative
stress. However, we had not previously investigated the consequences
of frataxin-deficiency on the thiol redox state of NRVM. In the present
work we have addressed this issue and we have found that frataxin-
deficient NRVM present an altered thiol redox state which impacts on
actin, and on the pyruvate dehydrogenase (PDH) complex. We have
also observed that an activator of PDH (dichloroacetate, DCA) and an
antioxidant (Tiron) can ameliorate the phenotype of frataxin-deficient
NRVM.
2. Results
2.1. Analysis of GSH status in frataxin-deficient NRVM
First, we were interested in analyzing the glutathione redox state in
the cardiac model of the disease previously developed by our group.
This model is based on lentivirus-mediated transduction of shRNAs
interfering frataxin into NRVM [19]. As indicated in Fig. 1A, this
strategy leads to a marked decrease in frataxin content. In order to
analyse the glutathione status in this model, GSH content was measured
by HPLC as described under experimental procedures. As shown in
Fig. 1D, we observed a marked decrease in GSH in frataxin-deficient
NRVM. We next analyzed the potential impact of such decreased GSH
content in protein glutathionylation. For this purpose, protein extracts
were prepared in non-reducing conditions and analyzed by Western
blot using anti-GSH antibodies. Results, shown in Fig. 1E, indicate the
appearance of a marked band (40kDa apparent molecular weight) in
frataxin-deficient cultures. In order to identify this protein, lysates from
frataxin-deficient NRVM were immunoprecipitated with anti-GSH an-
tibodies and the immunoprecipitated proteins separated by SDS-PAGE.
Oriole staining revealed the presence of a marked band of 40kDa ap-
parent molecular weight. This band was identified as actin by mass
spectrometry (Table 1). Interestingly, actin was previously identified as
a glutathionylated protein in FA derived patients fibroblasts [20,21].
Therefore our results confirm that actin is a target of glutathionylation
in FA.
2.2. Analysis of protein thiol redox state in frataxin-deficient cells
We were also interested in analyzing the presence of alterations in
the thiolproteome in frataxin-deficient NRVM. With this aim we de-
veloped a strategy to analyse global redox state of thiols in these cells.
To analyse the presence of reduced thiols, cells were lysed in the pre-
sence of the fluorescent alkylating reagent iodoacetamide-Bodipy (IAM-
Bodipy). Protein extracts were subsequently separated by SDS-PAGE
and Bodipy fluorescence was detected and quantified in a Chemidoc
XRS instrument. Gels were also stained with Oriole total protein stain as
a control for protein load. To detect oxidized thiols, cells were lysed in
the presence of iodocetamide, a reagent that blocks reduced thiols.
Oxidized thiols were then reduced with DTT and further alkylated with
IAM-Bodipy. Finally, these extracts were separated by SDS-PAGE and
Bodipy fluorescence was detected and quantified. In this case Bodipy
fluorescence indicated the presence of oxidized thiols, which had not
been blocked with iodocetamide and had been reduced by DTT. As
previously, gels were also stained with Oriole. Results from both ana-
lyses are shown in Fig. 2. Panel A indicates the workflow for detection
of reduced protein thiols and the results obtained. No significant dif-
ferences were observed in total bodipy fluorescence between SCR and
shFXN cells. Panel C shows the workflow for detection of oxidized
protein thiols and the results obtained. Samples non-treated with DTT
did not show Bodipy staining, confirming the efficiency of the iodoa-
cetamide (IAM) blocking step. In the DTT reduced samples, no sig-
nificant differences were obtained in total Bodipy fluorescence between
both conditions analyzed (quantitative results shown in Fig. 2B). These
results indicate that frataxin loss does not lead to a marked alteration of
the thiol proteome.
2.3. Identification of oxidized proteins by two-dimensional electrophoresis
Although in the previous section we did not observe a marked al-
teration in the redox state of the protein thiol groups, we hypothesized
that some specific proteins could be altered. Thus, we subjected these
cells to a more detailed analysis using two-dimensional electrophoresis.
Whole cell extracts from SCR and frataxin-deficient cardiomyocytes
were prepared for detection of oxidized thiols as described previously
and precipitated with chloroform/methanol before analysis by 2D
electrophoresis. Isoelectric focusing was performed in 11 cm IPG strips,
(pH range 3–10, non-linear), while SDS-PAGE was performed in 11%
22 cm x 20,5 cm gels. Two IPG strips were loaded side by side on the
same SDS-PAGE gel, one corresponding to SCR samples and the other
corresponding to shFxn samples. This approach had been used suc-
cessfully previously for the detection of carbonylated proteins using
fluorescent hydrazides [22]. We analyzed three samples for each con-
dition (each one from an independent experiment). After capturing the
Bodipy fluorescence (Fig. 3A), gels where stained with Flamingo total
protein stain (Fig. 3B) and images were analyzed with PDQuest soft-
ware. This analysis allowed us to obtain a Bodipy/flamingo (B/P) ratio
of those protein spots which were repetitively detected among the
different replicates in both the Bodipy and flamingo channel. We con-
sider this B/P ratio as an estimation of the relative degree of oxidation
of the thiol groups of these proteins. Only two spots showed significant
differences in the B/P ratio between both experimental conditions. On
average, spot 1 presented a 20% higher B/P ratio in frataxin-deficient
cultures, while spot 2 presented a 210% increase. A detailed image of
the gel region including these spots is shown in Fig. 3C. In order to
identify both spots, a preparative 22 x 20,5 cm 2D-gel was prepared in
which 200 μg of protein were separated and, after obtaining the Bodipy
signal, stained with Oriole total protein stain (Supplemental Fig. 1).
Spots were subjected to in gel tryptic digestion and analyzed by mass
spectrometry. Spot 1 was identified as ETF dehydrogenase and spot 2 as
dihydrolipoyl dehydrogenase (DLDH) (Table 1). We decided to focus on
DLDH due to its higher degree of oxidation and also to its potential
relationship with frataxin function, as biosynthesis of its substrate
(protein-bound lipoic acid) requires an iron-sulfur enzyme and cysteine
desulfurase [23].
2.4. Analysis of the content of DLDH and protein-bound lipoic acid
DLDH functions as the E3 component of three enzymatic complexes,
pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase
(KGDH) and branched chain α-ketoacid dehydrogenase (BCKDH).
These enzymatic complexes are also composed of the dehydrogenase
component E1 and the dihydrolipoamide transferase component E2,
which contains a covalently-bound lipoic acid. DLDH catalyzes the
conversion of this E2-bound dihydrolipoic acid and NAD + into lipoic
acid and NADH [24]. We decided to measure the content of DLDH and
E2-bound lipoic acid by Western blot. Using antibodies raised against
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this cofactor, two bands could be appreciated at 70 and 50 kDa ap-
parent molecular weight (Fig. 4A). The 70 kDa band (which is more
intense) corresponds to lipoic acid bound to the E2 component from
PDH (Dihydrolipoyllysine acetyltransferase, DLAT), while three lipoic
acid containing proteins migrate at 50 kDa: the E2 component from
KGDH (Dihydrolipoyllysine succinyltransferase, DLST), the E2 compo-
nent from the branched chain alphaketodehydrogenase complex and
the PDH-binding component X (a structural subunit from the PDH
complex) [24]. Among these three proteins, DLST is the more abundant
in heart according to the PaxDb database. Therefore, we assume that
most signal from the 50 kDa band is contributed by DLST. As indicated
in Fig. 4B, no significant changes where observed in DLAT-bound lipoic
acid nor in the 50 kDa lipoic acid band in shFxn NRVM. This result
indicates that protein-bound lipoic acid biosynthesis is not compro-
mised in frataxin-deficient NRVM. Also, no changes were observed in
the DLDH protein abundance measured by Western blot.
2.5. PDH-bound lipoic acid is more oxidized in frataxin-deficient cells
E2-bound lipoic acid contains two thiol groups that are oxidized by
Fig. 1. Frataxin deficiency in rat cardiomyocytes causes GSH depletion and actin glutahionylation. Rat cardiomyocytes were transduced with lentivirus
vectors containing shFxn or scrambled shRNA. A, cell lysates were probed with anti-frataxin antibody by Western blot analysis. In each gel lane, 30 ug of protein from
whole cell lysates were loaded. B, histogram represents the quantification of the relative expression of frataxin measured by Western blot. Data are represented as
means ± SEM from 3 independent cultures. In each experiment, frataxin signal in scrambled control cells were used as a 100% reference value. C, MTT cell viability
assay was performed in SCR and shFxn NRVMs. No significant loss in cell viability was observed in fratxin-deficient cultures. D, reduced glutathione content in
scrambled and frataxin deficient cells. E, lysates from the indicated NRVM cultures were analyzed by Western blot with anti-GSH antibody under non-reducing
conditions. Protein load was verified by post-western Coomassie blue (CBB) staining. Lysates from shFxn cells where also immunoprecipated with anti-GSH anti-
bodies and the immunoprecipitated proteins (IP) separated by SDS-PAGE and silver-stained.
Table 1
Proteins identified by mass spectrometry. The indicated proteins correspond to the immunoprecipitated band in Fig. 1D (IP) and to the spots from the 2d thiol-
proteome analysis shown in Fig. 3. All of them were identified by peptide mass fingerprinting (PMF) using MASCOT as search engine. Table shows the MOWSE
(MASCOT) score, number of matched and searched peptides, and sequence coverage of the proteins providing the highest score. MOWSE scores greater than 58 are
significant (p<0.01).
Spot/Band Uniprot Protein Name MOWSE Score Matched/Searched Sequence Coverage (%)
IP P62738 Actin, aortic smooth muscle 89 7/14 18
P68035 Actin, alpha cardiac muscle 1
1 Q6P6R2 Dihydrolipoyl dehydrogenase, mitochondrial 170 15/31 38
2 Q6UPE1 Electron transfer flavoprotein-ubiquinone oxidoreductase 374 29/34 44
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DLDH during each catalytic cycle. As we identified DLDH as an oxidized
protein, we hypothesized that frataxin-deficient cells could present li-
poic acid in a more oxidized form. Therefore we used an approach to
analyse the redox state of protein-bound lipoic acid. This approach
(summarized in Fig. 5A) was based on the analysis by western-blot of
lipoic acid in lysates treated or not with the thiol reactive reagent IAM.
Reduced lipoic acid would react with IAM and not be detected by an-
tibodies, while the oxidized one will not react with IAM and, after thiol
reduction, could be detected by antibodies. We then calculated the
signal ratio between IAM treated and not treated conditions to obtain
an estimate of the fraction of protein-bound lipoic acid oxidized under
each experimental condition. Results can be observed in figure 5B and
5C. In SCR NRVM the fraction of oxidized DLAT-bound lipoic acid was
45%, while 50kDa lipoic acid was mostly reduced. In shFxn NRVM, the
oxidized DLAT fraction increased significantly, while no changes where
observed in the 50kDa fraction. These results indicate that DLAT-bound
lipoic acid was more oxidized in frataxin-deficient cells.
2.6. Analysis of components of pyruvate dehydrogenase complex
The observation that DLAT-bound lipoic acid was more oxidized in
frataxin-deficient cells, prompted us to investigate the content of this
protein. We used an SRM-based targeted proteomics approach in which
proteotypic peptides from each protein were detected in a LC-triple
quadrupole mass spectrometer. For most proteins, this approach allows
a higher reproducibility than Western blot and also allows a better
comparison between samples and different proteins. We also included
in the analysis DLDH, the alpha subunit from the E1 component from
PDH (PDH A1), two iron-sulfur containg proteins (Succinate dehy-
drogenase 2 and Aconitase 2) as well as four additional mitochondrial
proteins, HSP60, GRP75, Citrate Synthase (CS) and Cytochrome C
(CYC), as a control of mitochondrial content. Actin, tropomiosin, and
myosin regulatory light chain were also analyzed and used as house-
keeping proteins to normalize protein load among samples. The results
from these analyses can be found in Fig. 6. We did not found alterations
in the content of DLAT or iron-sulfur containing enzymes. Interestingly,
Fig. 2. Detection of reduced and oxidized protein
thiols in lysates from shSCR and shFxn cardio-
myocytes. A, detection of reduced protein thiols.
Reduced protein thiols where derivatized with
Bodipy-IAM, separated by SDS-PAGE and fluores-
cence signal from Bodipy (blue) acquired in a
Chemidoc MP system. Gels where also stained with
Oriole protein stain (green). C, detection of oxidized
protein thiols. Reduced protein thiols where blocked
by IAM and oxidized ones reduced by DTT and de-
rivatized with Bodipy-IAM. B, relative protein thiol
redox state of shFxn calculated from the Bodipy
signal in A and C. Data are mean +/- SEM from three
independent experiments. (For interpretation of the
references to colour in this figure legend, the reader
is referred to the Web version of this article.)
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we found that frataxin-deficient NRVM present a significant decrease in
the content of PDH A1. This observation confirms that PDH is altered in
frataxin-deficient NRVMs.
2.7. Tiron and dichloroacetate supplementation partially prevent lipid
droplet accumulation caused by frataxin deficiency
We decided to analyse the potential benefit for frataxin-deficient
NRVMs of several compounds impacting on the pathways investigated
in the previous sections. The compounds used where expected to work
as antioxidants and/or PDH activators, and they were lipoic acid,
thiamine (precursor of the PDH cofactor thiamine pyrophosphate), di-
chloroacetate (DCA, a PDH activator), the glutathione precursor N-
acetyl cysteine (NAC), and the superoxide-scavenger mitochondria-
targeted Tiron (4,5-dihydroxy-1,3-benzenedisulfonic). First, we tested
the effect of supplementation with these compounds on the increased
presence of enlarged mitochondria, which can be revealed (and quan-
tified) by TMRM staining and fluorescence microscopy. This
Fig. 3. Two-dimensional thiol proteome
analysis of NRVM. SCR and frataxin-defi-
cient cultures were processed and analyzed
as described in material and methods.
Representative analytical gels containing
SCR and shFxn samples are shown in A
(Bodipy signal, which corresponds to oxi-
dized thiol groups) and B (Flamingo signal,
which corresponds to total protein stain).
The indicated spots are those showing sig-
nificant differences in their ratio Bodipy/
flamingo; C, amplified image of the gel re-
gion containing spots 1 and 2; D, histograms
show the relative Bodipy/protein ratio from
spots 1 and 2. Data are mean +/- SEM from
three independent experiments.
Fig. 4. Analysis of lipoic acid containing dehy-
drogenase complexes by Western blot. A, Western
blot analysis of shSCR and shFxn NRVMs using DLDH
or lipoic acid (LA) antibodies. B, histogram re-
presents the quantification of the relative Western
blot signal (ratio shFxn to shScr). Data are re-
presented as means ± SEM from 3 independent
cultures.
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phenomenon is caused by mitochondrial permeability transition pore
opening and is one of the most marked mitochondrial phenotypes ob-
served in frataxin-deficient NRVMs [25]. Thus, SCR and shFxn NRVM
cultures were subjected to different concentrations of the indicated
compounds and, after 7 days, stained with TMRM. Images (shown in
Figs. 7 and 8) were acquired in an Olympus inverted microscope and
the presence of enlarged mitochondria analyzed with ImageJ software.
As previously reported, marked differences were observed between SCR
and shFxn NRVM in the number of enlarged mitochondria per cell. This
phenotype was only slightly reversed by Tiron at 50 μM concentration,
while no significant differences in the amount of enlarged mitochondria
were observed upon treatment with any of the other compounds tested.
Actually, treatment with lipoic acid or thiamine worsened the pheno-
type. We next decided to analyse the effect of Tiron and DCA on lipid
droplet accumulation, which is another consequence of frataxin defi-
ciency in NRVM. The antioxidant tiron and the PDH activator DCA were
selected because they presented better results than NAC and thiamine
respectively in the enlarged-mitochondria assay. Therefore, presence of
lipid droplets was analyzed by Bodipy staining in SCR and shFxn cul-
tures supplemented with these compounds. As shown in Fig. 9, Tiron at
5 and 50 μM concentrations was able to partially rescue the accumu-
lation of lipid droplets, confirming its protective effect on frataxin-de-
ficient NRVM. We also analyzed by targeted proteomics whether Tiron
could reverse the content of PDHA1 in frataxin-deficient cells. As shown
in Fig. 9, PDHA1 deficiency was not reversed by tiron, indicating that
its beneficial effects are not caused by a reversion of PDHA1 deficiency.
Regarding DCA, this compound activates PDH by inhibiting pyruvate
dehydrogenase kinase, a protein that phosphorylates PDHA1 in order to
modulate its activity in response to metabolic requirements [26].
Therefore, we first analyzed by Western blot the effects of DCA sup-
plementation on the content and phosphorylation state of PDHA1. As
shown in Fig. 10, these analyses confirmed the decreased content of
PDHA1 in frataxin-deficient NRVM (previously observed by targeted
proteomics). We could also observe that phosphorylation state of this
protein was not markedly altered in frataxin-deficient cells, as signal
from the phosphorylated form decreases similarly than total protein
signal. The phosphorylated form was significantly decreased in both
conditions (SCR and shFxn) in 9 mM DCA-supplemented cultures. This
treatment did not change the content of PDHA1 in shFxn, although it
decreased its content in SCR. This observation indicated that in shFxn
NRVMs, PDHA1 would be activated by DCA at 9 mM concentration.
Next, we analyzed the presence of lipid droplets in these cultures by
Bodipy staining. As shown in Fig. 10, DCA at 9 mM concentration
prevented the accumulation of lipid droplets in frataxin-deficient
NRVMs. In summary, these results indicate that neither the antioxidants
used nor the activators of PDH are able to prevent markedly the altered
mitochondrial phenotype (mitochondria enlargement assay) but may
partially reverse the consequences of frataxin deficiency (as indicated
by the lipid droplet assay).
3. Discussion
In this work we have performed an analysis of the protein thiol
redox state of frataxin-deficient NRVM. The analysis has provided
several conclusions. First, frataxin-deficient cardiomyocytes present an
altered thiol redox state, revealed by the decreased GSH content and the
increased presence of glutahionylated actin. Second, such altered thiol
redox state may impact specific proteins (such actin), but there is not a
general alteration in the thiol proteome of frataxin-deficient NRVM.
Third, alterations can be found in the PDH complex, both in the redox
state of DLAT-bound lipoic acid and on the content of its PDH A1
subunit.
Fig. 5. Redox state from protein-bound lipoic
acid. NRVMs where lysed in the presence or not of
iodoacetamide (IAM), reduced by DTT and analyzed
by Western blot using lipoic acid (LA) antibodies. A,
schematic representation of the experimental proce-
dure used. Reduced lipoic acid will not be detected in
IAM-treated samples. B, representative lipoic acid
western from samples treated or not with IAM. C,
relative lipoic acid oxidized fraction was calculated
from the ratio between the Western blot signal from
samples treated or not treated with IAM. Data are
represented as means ± SEM from 4 independent
experiments. * indicates significant (p< 0.05) dif-
ferences between shSCR and shFxn conditions.
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Altered GSH/GSSG ratio and increased presence of glutathionylated
actin have been previously reported in patient-derived cells (lympho-
blasts and fibroblasts) and frataxin-deficient yeast [20,21]. Our results
indicate that these alterations can also be observed in a cardiac cell
model and therefore confirm that frataxin-deficient cells are experien-
cing an oxidative stress condition which may cause oxidation of sen-
sitive proteins such actin. However, it is not clear which can be the
consequence of such glutahionylation on actin function. This mod-
ification is known to impact on actin polymerization [27,28] and could
also be related to the impaired NRF2 activation which has been
observed in some models of FA [10]. In this regard, the inability to
induce NRF2-dependent antioxidant enzymes to counteract oxidative
stress could lead frataxin-deficient NRVM to a vicious cycle which
would increase its sensitivity towards oxidative stress. Besides actin and
DLDH, we have not been able to identify other proteins with an altered
thiol redox state. Therefore, we can conclude that there is not a general
affectation in the protein thiol redox state. Nevertheless, there could be
additional oxidized proteins that have not been detected in this study.
This may be due to limitations of the approaches used, which may not
be able to detect low abundant proteins or (in the case of 2D
Fig. 6. Protein content analysis by targeted proteomics. A, a representative chromatogram showing the SRM traces of the different peptides analyzed in the
targeted proteomics experiment. B, representative signals from the three transitions detected for the peptide AILAELTGR, corresponding to PDH A1. Top panel
corresponds to the detection of the “light” version of the peptide obtained from the tryptic digestion of whole cells lysates, while low panel corresponds to the
detection of the standard, a C13N15 labeled “heavy” version of the peptide. C, Histograms show the relative content (in arbitrary units) of the measured proteins by
targeted proteomics. Data are represented as means ± SEM from 4 independent experiments. * indicates significant (p< 0.05) differences between shSCR and
shFxn conditions.
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electrophoresis) those with transmembrane domains. This limitation
could explain why we have only identified two proteins in this analysis.
Therefore, the altered thiol redox state observed in this work could
have an impact on several cellular processes. In this regard, various
types of thiol redox modifications, including S-oxidation (sulfenylation
and sulfinylation), S-glutathionylation, and S-nitrosylation have been
described to regulate a number of mitochondrial processes ranging
from OXPHOS to mitochondrial permeability transition pore opening
[29].
The identification of DLDH as an oxidized protein led us to the study
of lipoic acid containing proteins. We detected a decreased content of
PDHA1 and a higher proportion of oxidized DLAT-bound lipoic acid.
Both events could be related, as PDHA1 provides electrons to lipoic acid
which are then transferred to DLDH. Therefore, a decreased content of
PDHA1 could result in accumulation of oxidized forms of lipoic acid
and DLDH. Otherwise, DLAT-bound lipoic acid could be oxidized by
oxidized glutathione, as it has been previously described to occur with
DLST-bound lipoic acid [30]. This modification, upon rapid disulfide
exchange, may produce oxidized lipoic acid and reduced glutathione. In
any case, the mechanism causing PDHA1 deficiency in frataxin-defi-
cient NRVMs is not known. A proteomic analysis of frataxin-deficient
yeast revealed that mitochondrial Mg-binding proteins (as PDHA1) are
prone to experience oxidative modifications due to iron-catalyzed oxi-
dation [31]. Therefore, this mechanism could apply for PDHA1.
Nevertheless the PDHA1 yeast orthologue was not identified in that
study as an oxidized protein. Also, in the present study Tiron supple-
mentation has not prevented PDHA1 deficiency. This compound has
both antioxidant and iron chelating properties and is able to reach
mitochondria [32]. Thus, it should be able to prevent the iron-catalyzed
oxidation phenomenon observed in yeast. Understanding the me-
chanism causing PDHA1 deficiency will require further investigation.
Nevertheless, some early investigations reported a dysfunction of
lipoamide dehydrogenase [32,33] and of the pyruvate and oxoglutarate
dehydrogenase complexes in FA patients [34], although these
Fig. 7. Supplementation with compounds impacting on PDH. NRVM cultures were supplemented with the indicated concentrations of lipoic acid, thiamine and
DCA, and, after 7 days of frataxin depletion, mitochondria were stained with TMRM (A, C and E). The amount of enlarged mitochondria was measured with ImageJ
(B, D and F). Graphs represent the relative number of enlarged mitochondria relative to non-treated FXN deficient cells values. Scale bar = 30μm.
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observations were not confirmed by other studies [35]. Recently, PDH
deficiency was found in a proteomic analysis of peripheral blood
mononuclear cells from FA patients [36]. Previous studies had also
observed low levels of thiamine in the cerebrospinal fluid of patients
with FA [37]. Therefore, several evidences point to a potential un-
balance in the thiamine and PDH axes in this disease. In this regard,
more recently, thiamine administration was tested in a group of FA
patients. These patients showed an improvement in neurological
symptoms. A subgroup of patients which were subjected to echo-
cardiogram analysis showed also a reduction in interventricular septum
thickness. The authors of this study concluded that further studies
where mandatory to confirm restorative and neuroprotective action of
thiamine in FA [38]. In a similar way, we also conclude that further
studies are required to understand the causes of PDHA1 deficiency in
frataxin-deficient NRVM and also its potential contribution to pa-
thology. In this regard, the DCA experiments performed in this work
indicate that activation of PDH could have a beneficial impact on the
metabolic alterations caused by frataxin-deficiency (as DCA prevented
the accumulation of lipid droplets). Nevertheless, lipid droplet accu-
mulation is not directly caused by PDHA1 deficiency, as this phenotype
is partially prevented by Tiron whithout correcting PDHA1 deficiency.
Probably, lipid dropled accumulation is related to several impaired
mitochondrial functions caused by frataxin deficiency, and any treat-
ment which partially ameliorates these functions may have a beneficial
effect on lipid droplet accumulation. In this regard, we have previously
shown that lipid droplet accumulation can be corrected by inhibitors of
the mitochondrial permeability transition pore [39].
Besides its relation with the PDH complex, analysis of lipoic acid
had an additional interest, because synthesis of this cofactor is depen-
dent on iron-sulfur enzymes. Therefore, it is commonly used as a
marker of the presence of these cofactors in the cell. Nevertheless, no
differences in the total amount of lipoic acid could be observed between
SCR and frataxin-deficient cells. We have also not observed a decreased
content of the iron-sulfur enzymes Aconitase 2 and SDH2, a result
which is consistent with previous observations reporting normal aco-
nitase and complex II activities in this same model [19]. Overall, we can
confirm that iron-sulfur cluster biogenesis is not seriously compromised
in frataxin-deficient NRVMs. It is worth mentioning that iron-sulfur
cluster deficiency is not always observed in FA models. In this regard,
studies in yeast have shown that loss of iron-sulfur enzymes in frataxin-
deficient cells would be mostly caused by metabolic remodelling and/or
by oxidative stress [40,41].
In summary, the proteomic approach deployed has revealed that
frataxin deficiency in NRVM causes an imbalance on the cellular thiol
Fig. 8. Supplementation with antioxidants. NRVM cultures were supplemented with the indicated concentrations of N-Acetylcysteine (NAC) and Tiron and, after 7
days of frataxin depletion, mitochondria were stained with TMRM (A and C). The amount of enlarged mitochondria was measured with ImageJ (B and D). Graphs
represent the relative number of enlarged mitochondria relative to non-treated FXN deficient cells values. Only 50 μM Tiron treatment shows a significant decrease in
the number of enlarged mitochondria in FXN interfered cells. Scale bar = 30 μm. # indicates statistic significance to non-treated shFxn (p< 0,05).
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redox state and in PDH enzymatic complex. These results encourage the
investigation of these pathways in animal models of the disease. In this
regard, FA is a progressive disease, and the cardiac symptoms do not
always appear in the early stages. This progressive and chronic condi-
tion is not reproduced by our cell culture model. Therefore, it would be
interesting to follow the evolution of the alterations found in this work
in animal models and correlate their presence with the appearance of
cardiac symptoms. It is worth commenting that mutations in PDHA1
cause a variety of clinical signs, which affect metabolic and neurolo-
gical processes. These symptoms depend on the residual PDH activity
presented by the mutated form and, in females, on Chromosome X in-
activation (PDHA1 is an X‐chromosomal gene) [42]. Therefore, PDHA1
deficiency could contribute to FA pathology. We have also found that
Tiron and DCA have a positive impact on frataxin-deficient cells. This
observation should also encourage the testing in animal models of these
compounds, which could be in the future included in the FA treatment
pipeline.
4. Experimental procedures
4.1. Isolation and culture of NRVM
The investigation with experimental animals conforms to the
National Guidelines for the regulation of the use of experimental la-
boratory animals from the Generalitat de Catalunya and the
Government of Spain (article 33.a 214/1997) and was evaluated and
approved by the Experimental Animal Ethic Committee of the
University of Lleida (CEEA). P3–P4 Sprague–Dawley rat neonates were
sacrificed, following the above Guide approved by the CEEA, by de-
capitation and (NRVM) were obtained from the hearts as described
previously [19]. Briefly, ventricles from newborn rats were minced and
cells were isolated by 3 subsequent digestion steps with 150U/ml of
type-2 collagenase (Worthington, USA) stirring at 37 °C. Non-cardio-
myocyte cells were separated from the cardiomyocytes by differential
preplating. Cardiomyocytes were seeded on 0.2% gelatin-coated culture
dishes (Falcon, Becton & Dickinson, USA) at 7.5·104 cells/cm2, giving a
confluent monolayer of spontaneously contracting cells after 24 h. To
inhibit the proliferation of cardiac fibroblasts, cells were treated with
10 μg/ml mitomycin C (SIGMA) for 4 h after the seeding time. The
culture medium used was DMEM:M199 3:1, 5mM glucose, with 8%
horse serum and 4% fetal bovine serum, glutaMAX and HEPES (all from
GIBCO). Cardiomyocyte purity was checked by immunofluorescence
with a specific cardiac α-actinin antibody (SIGMA) and was found to be
higher than 90% after 24 h in vitro. To analyse lipid droplet accumu-
lation fatty acid-albumin solutions were used for FFA supplementation
of the culture media. These solutions where prepared as described [19].
These solutions where added to the culture medium to give a final
concentration of 30 μM each of linoleic, oleic and stearic acid, and
60 μM palmitic acid.
Fig. 9. Tiron supplementation pre-
vents lipid droplet accumulation.
NRVM cultures were supplemented
with the indicated concentrations of
Tiron and, after 7 days of frataxin de-
pletion, lipid droplets were stained
with Bodipy 493/503 (A). The number
of lipid droplets per cell was measured
with ImageJ (B). Graphs represent the
relative number of lipid droplets re-
lative to non-treated FXN deficient cells
values. C, Histograms show the relative
content (in arbitrary units) of the
measured proteins by targeted pro-
teomics. Data are represented as
means ± SEM from 3 independent
experiments. *(p< 0.05) and **
(p<0.01) indicate significant differ-
ences between shSCR and shFxn con-
ditions. # indicates statistic sig-
nificance to non-treated shFxn
(p<0,05).
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4.2. Production of lentiviral particles
The shRNA lentiviral plasmids (pLKO.1-puro) for human/mouse/rat
frataxin were purchased from SIGMA. The RefSeq used were
NM_008044, which correspond to mouse frataxin. The clone
TRCN0000197534 (named shFxn in this study) is designed for mouse
frataxin interference in a region 100% identical to rat Frataxin. A non-
targeted scrambled sequence (the vector SHC002, named shSCR in this
study) served as a control. Lentiviral particles were produced by co-
transfection of HEK293T cells using the plasmids pMD2.G and psPAX2
(Addgene) and polyethylene as described previously [43]. After 3 days,
lentiviruses were collected from the culture medium, centrifuged for
5 min at 1000 rpm, filtered through a 0.45 μm filter (Millipore), con-
centrated by centrifugation through 100,000 MWCO Vivaspin 20 col-
umns (Sartorius) and stored at −80 °C. Lentiviruses were tittered using
the Quicktiter Lentivirus ELISA kit (Cell Biolabs), which detects the
amount of p24 protein. For NRVM transduction, 5.5 ng of p24 per
1,000 cells were added to the media 4 h after plating, and 20 h later,
culture media was replaced with fresh media. This protocol provided a
transduction efficiency greater than 70%.
4.3. Western blot
Cells were first rinsed in ice cold PBS and lysed in 2% SDS, 125mM
Tris, pH 6,8 containing a protease inhibitor cocktail (Roche). Protein
concentration was determined by the Qubit assay (Invitrogen). After
SDS-polyacrylamide gel electrophoresis, proteins were transferred to
Immobilon-P or Nitrocellulose membranes. The membranes were
probed with the following primary antibodies: Frataxin (sc-25820),
DLDH (Sigma SAB2100589), GSH (abCam, ab19534), lipoic acid
(Calbiochem, 437695), phosphoPDHA1 (abcam, ab177461), PDHA1
(abcam, ab110334). Detection was performed using peroxidase con-
jugated secondary antibodies. Image acquisition was performed in a
ChemiDoc MP system from Bio-Rad. When required, data was analyzed
by Image Lab software (Bio-Rad).
Fig. 10. DCA supplementation decreases PDHA1
phosphorylation and prevents lipid droplet ac-
cumulation. NRVM cultures were supplemented
with the indicated concentrations of DCA. (A and B),
Western blot analysis indicates that DCA at 9 mM
inhibits PDHA1 phosphorylation in shFxn without
affecting protein levels. (C) Lipid droplets were
stained with Bodipy 493/503. (D) The number of
lipid droplets per cell was measured with ImageJ.
Graphs represent the relative number of lipid dro-
plets relative to non-treated FXN deficient cells va-
lues. Data are represented as means ± SEM from 3
independent experiments. *(p<0.05) and **
(p<0.01) indicate significant differences between
shSCR and shFxn conditions. # (p< 0,05) and ##
(p<0,01) indicate statistic significance to non-
treated shSCR or shFxn.
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4.4. MTT cell viability assay
For the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay, cells were grown in 96-well plates and 7 days after
lentivirus transduction, cells were rinsed and labeled with 0.2 mM MTT
for 4 h at 37 °C and 5% CO2 in HBSS with calcium, magnesium and
5 mM glucose. The precipitates were dissolved in DMSO and absor-
bance was read at 540 nm in a Biotek Power Wave XS.
4.5. Analysis of protein-bound lipoic acid redox state
Cells were first rinsed in ice cold PBS and lysed in 50 μl of lysis
buffer (10 mM Tris, 1mM EDTA, 1% SDS) and divided in two parts. To
one part, 1/3 volume of loading buffer was added. The other part was
incubated for 30 min at 37 °C in the presence of 50 mM IAM before the
addition of 1/3 volume of loading buffer. Proteins (10 μg) where se-
parated by SDS-PAGE and after electrophoresis transferred to
Immobilon-P membranes. The membranes were probed with antibodies
against lipoic acid and Western blot images where acquired in a
ChemiDoc MP system from Bio-Rad. Data was analyzed by Image Lab
software (Bio-Rad)
4.6. Fluorescent thiol labelling
For labelling reduced protein thiols, cells (750,000) where washed
twice with cold PBS and lysed with 200 μl of lysis buffer (10 mM Tris,
1mM EDTA, 1% SDS) plus 0,4 mM IAM-Bodipy (BODIPY™ FL
Iodoacetamide, Thermo Fisher ref. D6003) and incubated for 30 min at
37 °C. The IAM moiety of this compound will react with reduced thiol
groups, while the Bodipy moiety will provide fluorescence labelling
without affecting protein charge. Reaction was stopped by addition of
1/3 volume of loading buffer (20% sacarose, 0,1% sodium azide, 15%
β-mercaptoethanol, bromphenol blue). Proteins (10 μg) where sepa-
rated by SDS-PAGE and after electrophoresis, reduced protein thiols
were visualized by epifluorescence in a ChemiDoc MP imager (BioRad)
using specific channel settings for Bodipy (Blue LED, 530/28 filter).
Once this image was captured, total protein was stained with OrioleTM
total protein fluorescent gel stain (Bio-Rad) and the resulting images
were superimposed on those obtained from the Bodipy channel. Oriole
is a stain for visualization and quantitation of proteins separated by
SDS-PAGE. Its fluorescence was recorded in a ChemiDoc MP imager
using UV-excitation. Oriole signal does not interfere with Bodipy
fluorescence. Images were analyzed with Image Lab software (Bio-Rad).
For labelling oxidized protein thiols, cells (750,000) where washed
twice with cold PBS and lysed with 200 μl of lysis buffer plus 50 mM
IAM. After 30 min of incubation at 37 °C, 1,600 μl of cold acetone
where added to the lysate and samples where incubated in ice for
30 min. Proteins where precipitated by centrifugation, washed once
with cold acetone, and resuspended in lysis buffer plus 2.5 mM DTT.
After 30 min of incubation at 37 °C, proteins where precipitated again
with acetone as before. Pellets where resuspended with 10 mM Tris,
1 mM EDTA, 2% SDS, 0.4 mM IAM-Bodipy and incubated for 30 min at
37 °C. For monodimensional SDS-PAGE analysis, reaction was stopped
by addition of 1/3 volume of loading buffer and analyzed by SDS-PAGE
as indicated for reduced thiols. For two-dimensional electrophoresis,
reaction was stopped by addition of 5 mM DTT and analyzed as in-
dicated below.
4.7. GSH quantitation and immunoprecipitation
GSH was analyzed by HPLC chromatography using 5,5′-Ditiobis-(2-
nitrobenzoic acid) (DTNB) as derivitizing reagent [44]. Briefly, cells
(approximately 200,000) were washed twice with cold PBS and sus-
pended in 75 μl of 0,3% sulfosalicylic acid. This cell suspension was
lysed in a Mini-Beadbeater-16 (BioSpec) in the presence of 0.5 mm glass
beads. Lysates were centrifuged and 10 μl of the supernatant where
mixed with 10 μl PBS and 80 μl DTNB 1 mM (diluted in PBS). This
mixture was incubated for 10 min at room temperature and after cen-
trifugation, supernatant analyzed in an Agilent 1260 Infinity HPLC
system equiped with an UV–visible detector operating at 330 nm. A
Phenomenex Kromasil 5μm 100A (4,6 × 25 mm) column operating at
1 ml/min in isocratic mode was used. Solvent was ammonium acetate
20 mM 10% methanol pH5. For immunoprecipitation, 750,000 cells
were lysed with 200 μl of IP solution composed of 50 mM Tris pH 7,
1 mM EDTA, 150 mM NaCl, 0,1% Triton, 0,1% deoxycholate and
protease inhibitors. Samples were centrifuged for 3 min at 3000g (4 °C)
and supernatant was mixed with a suspension of Protein G Dyna-
beadsTM (ThermoFisher) and anti-GSH antibody (#ab19534). This
suspension was incubated for 30 min at 4 °C minutes under agitation.
Not-bound proteins were separated from Dynabeads using a magnetic
support. After three additional washes with 200 μl of IP solution to
minimize non-specific binding to Dynabeads, these were suspended in
elution buffer (10 μM DTT in IP solution) and incubated for 10 min to
allow reduction of the mixed disufides between glutathione and protein
thiols. Eluted protein were separated by SDS-PAGE.
4.8. Two-dimensional electrophoresis
Protein lysates derivatized with IAM-Bodipy where precipitated
with methanol/Chloroform. The resulting protein pellet was re-
suspended in 100 μl 2-D Protein Extraction Buffer -V (PEB-V, GE
Healthcare). After 2 h incubation at 25 °C, the solution was centrifuged
and the supernatant conserved. Protein concentration was quantified
using the Bio-Rad Protein Assay. For analytical gels, a supernatant
volume containing 80 μg protein was diluted in 200 μl PEB-V con-
taining 50 mM DTT and 2 μl Bio-lytes. This solution was used to re-
hydrate 11 cm IPG strips (3–10 NL, Bio-Rad) for 12 h and then focused
using a Protean IPG Cell (Bio-Rad) for a total 24000Vhr. After iso-
electric focusing, strips were incubated for 15 min in 6 M urea, 2% SDS,
20% glycerol, 375 mM Tris pH 8,8 and 130 mM DTT. Second dimension
was performed in an EttanDalt 6-electrophoresis system (GE
Healthcare). Two parallel 11-cm strips (shScr and shFxn samples) were
loaded side by side on the same 10% polyacrylamide gel (crosslinker
ratio 37,5:1). After electrophoresis, oxidized protein thiols were vi-
sualized by epifluorescence in a VersaDoc MP4000 imager (BioRad)
using specific channel settings for Bodipy. Once this image was cap-
tured, the total protein was stained with Flamingo fluorescent gel stain
(Bio-Rad) and the resulting images were superimposed on those ob-
tained from the Bodipy channel. Images were analyzed with PDQuest
Advanced software (Bio-Rad). Flamingo protein stain was used in 2D-
analysis as it provides higher sensitivity than Oriole protein stain.
4.9. Protein identification by peptide mass fingerprinting
Protein spots were excised from gels and subjected to in gel diges-
tion as described [22]. Tryptic peptides were recovered and spotted
onto a MALDI plate in the presence of α-cyano-4-hydroxy-cynamic acid.
Mass spectra were acquired in a Bruker Ultraflex MALDI-TOF/TOF
operating in a reflector positive mode. Proteins were identified by
peptide mass fingerprint, searching against UniProt database using
MASCOT. Search criteria assumed that peptides were monoisotopic,
oxidized at methionine residues (variable modification), and carbami-
domethylated at cysteine residues (fixed modification). One maximum
missed cleavage was allowed with a maximum peptide mass tolerance
of 50 ppm.
4.10. Protein quantitation by targeted proteomics
Cells were resuspended in 125 mM Tris-HCl, 2% SDS plus 1 mM
EDTA and a mixture of protease inhibitors, boiled for 3 min and cen-
trifuged (12000 rpm 10 min). Proteins were quantified using the BCA
assay (Thermo Scientific) and 30 μg were precipitated with cold
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acetone (9 vol) and resuspended in 1% sodium deoxycholate, 25 mM
ammonium bicarbonate. Then, proteins were subjected to reduction by
12 mM DTT and alquilation by 40 mM IAM. Mass spectrometry grade
trypsin (SOLu-Trypsin, Sigma) was added to a final enzyme:substrate
ratio of 1:50. After overnight digestion at 37 °C, formic acid was added
to precipitate sodium deoxycholate. The resulting peptide mix was
purified and enriched using C18 columns (Pierce C-18 Spin Columns,
Thermo Scientific). Eluted fraction from the C18 column was evapo-
rated using a Concentrator Plus (Eppendorf) and peptides were re-
suspended in 3% acetonitrile plus 0,1% formic acid containing a heavy
peptide standards mixture. Heavy peptides were obtained from JPT
(SpikeTidesTM_L). All peptide samples were analyzed on a triple
quadrupole spectrometer (Agilent 6420) equipped with an electrospray
ion source. Chromatographic separations of peptides were performed
on an Agilent 1200 LC system using a Supelco Bioshell A160 Peptide
C18 column (1 mm × 15 cm). Peptides (up to 15 μg of protein digest)
were separated with a linear gradient of acetonitrile/water, containing
0.1% formic acid, at a flow rate of 75 μl/min. A gradient from 3 to 60%
acetonitrile in 45 min was used. The mass spectrometer was operated in
multiple reaction monitoring mode. Transitions were obtained from
SRM atlas and imported into Skyline software [45], which was also
used to analyse results. In the SRM assays validation phase, the tran-
sitions obtained from SRM atlas were analyzed in several runs. Each
MRM acquisition was performed with Q1 and Q3 operated at unit re-
solution. Once validated and optimized, the SRM assays were used to
quantify all the analyzed peptides using scheduled SRM mode in a
single run (retention time window, 120 s; cycle time, 1 s). For calcu-
lating protein content, the light to heavy ratio of each peptide in each
sample was first divided by the mean value of that peptide between all
samples. Then, this value was normalized to the average value of the
housekeeping proteins in each sample. The peptides and transitions
analyzed can be found in supplemental table 1.
4.11. Subcellular labelling and image analysis
To analyse mitochondrial swelling, NRVM cells were loaded with
30 nM TMRM for 1 h as described [19]. The number of “balloon-like”
swollen mitochondria was assessed using the “analyse particles” tool
from ImageJ software. Images were background-subtracted and the
following criteria were used to detect particles: size higher than 2 μm2
and circularity 0.5–1. For labelling of lipid droplets, cells were washed
with PBS and loaded with 5 μM Bodipy 493/503 (Invitrogen) for
10 min at 37 °C. Nuclei staining with 0.05 μg/ml Hoechst 33258 was
done as necessary. An Olympus IX71 microscope equipped with epi-
fluorescence optics and a DP70 CCD camera was used to obtain images
with a 40x lens.
4.12. Statistical analysis
All experiments were performed in at least 3 completely in-
dependent cardiomyocyte preparations. Values were expressed as
mean ± SEM (error bars). The data obtained from the independent
experiments were used for statistical analysis. Data obtained was
compared with control conditions using Student t-test. The p-values
lower than 0.05(*) or 0.01(**) were considered significant.
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